A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Condition:   Alopecia, Androgenetic Interventions:   Drug: Clascoterone 5% solution;   Drug: Vehicle solution Sponsors:   Cassiopea SpA;   Ergomed PLC;   Pharmapace Inc;   Canfield Scientific Inc.;   ICON Clinical Research Not yet recruiting

Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials